Pacific Biosciences
PACB
PACB
262 hedge funds and large institutions have $6.03B invested in Pacific Biosciences in 2021 Q2 according to their latest regulatory filings, with 46 funds opening new positions, 97 increasing their positions, 73 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
1.91% more ownership
Funds ownership: 85.12% → 87.04% (+1.9%)
0% more first-time investments, than exits
New positions opened: 46 | Existing positions closed: 46
0% less funds holding
Funds holding: 263 → 262 (-1)
Holders
262
Holding in Top 10
6
Calls
$41.4M
Puts
$35.7M
Top Buyers
| 1 | +$85.2M | |
| 2 | +$83.6M | |
| 3 | +$56M | |
| 4 |
Goldman Sachs
New York
|
+$41M |
| 5 |
Viking Global Investors
Stamford,
Connecticut
|
+$28.5M |
Top Sellers
| 1 | -$78.9M | |
| 2 | -$34M | |
| 3 | -$32M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$23.8M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$15.8M |